E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Under the partnership, Cipla will receive exclusive rights to develop and commercialise TQB2102 in India, South Africa and five other emerging markets.
imphoenix82
Lilly aims to advance treatments for serious autoimmune and allergic diseases with the Merida acquisition. The transaction is expected to close in the fourth quarter of 2026.
imphoenix82
Industry experts, academicians and stakeholders will discuss recent advancements and standardisation efforts aimed at enhancing the quality and safety of medical device packaging and sterilisation in India.
imphoenix82
For people at high risk of a heart attack or stroke, lowering LDL-C with Repatha may not only prevent these events but also reduce the risk of death from cardiovascular disease, according to Amgen.
imphoenix82
Ascendis Pharma will pay royalties to BioMarin on Yuviwel sales in the US, EU, Brazil and South Korea.
imphoenix82
The launch of the phytochemical and botanical reference standards marked a significant advancement in the scientific standardisation, quality assurance and regulatory evaluation of plant-derived medicinal products
imphoenix82
The Department of Pharmaceuticals (DoP) has announced the second call for applications under the Promotion of Research and Innovation in Pharma and MedTech (PRIP) Scheme, aimed at strengthening India’s pharmaceutical and medical technology research and development ecosystem. Launched in 2023 with a financial outlay of INR 5,000 crore, the PRIP Scheme seeks to support startups, […]
imphoenix82
DualityBio will generate and develop ADCs against oncology targets selected by Genentech, using payloads from its DUPAC platform.
imphoenix82
Evonik’s over 150 million CAD investment project is supported with up to 68 million CAD in external funding from the Canadian federal government’s Strategic Response Fund.
imphoenix82
Olympus’ POWERSEAL Open Extended Jaw Sealer/Divider is designed to provide reliable sealing of vessels up to and including 7mm in diameter during open surgical procedures.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
